MAX
スケジュール AdvisorShares Psychedelics ETF
簡単なスケジュール
拡張スケジュール
主なパラメーター
| 10夏の収益性 | 0 |
| 3夏の収益性 | 32.79 |
| 5夏の収益性 | 0 |
| Webサイト | システム |
| isinコード | US00768Y3624 |
| カントリーイソ | US |
| トップ10発行者、％ | 57.12 |
| ベースの日付 | 2021-09-15 |
| ベータ | 0.4 |
| 企業の数 | 13 |
| 国 | USA |
| 地域 | Global |
| 平均P/BV | 1.75 |
| 平均P/E | 9.46 |
| 平均P/s | 2.15 |
| 年間収益性 | 20.42 |
| 所有者 | AdvisorShares |
| 手数料 | 0.99 |
| 神の収益性 | 0.31 |
| 索引 | ACTIVE - No Index |
| 資産タイプ | Equity |
| 通貨 | usd |
| その日の変化 | 0% 17.028 $ |
| 今週の変化 | -1.6% 17.305 $ |
| 1か月後に変更されます | -0.83% 17.17 $ |
| 3か月で変化します | -8.5% 18.61 $ |
| 6か月で変化します | -16.42% 20.373 $ |
| 今年の変更 | +20.42% 14.14 $ |
| 年の初めから変化します | -2.54% 17.472 $ |
サブスクリプションを支払います
企業とポートフォリオの分析のためのより多くの機能とデータは、サブスクリプションで入手できます
トップ企業
| 名前 | 業界 | 共有, % | P/BV | P/S | P/E | EV/Ebitda | 配当利回り | |
| #1 |
 COMPASS Pathways plc |
Healthcare | 7.8644 | 1.65 | 0 | -1.91 | -0.69 | 0 |
| #2 |
 Alkermes plc |
Healthcare | 7.7698 | 3.32 | 3.13 | 13.27 | 9.4 | 0 |
| #3 |
 Relmada Therapeutics, Inc. |
Healthcare | 6.6722 | 0.39 | 0 | -0.21 | -0.12 | 0 |
| #4 |
 GH Research PLC |
Healthcare | 6.1726 | 2.04 | 0 | -17.08 | -6.96 | 0 |
| #5 |
 Neurocrine Biosciences |
Healthcare | 5.8272 | 5.49 | 6.03 | 41.64 | 22.57 | 0 |
| #6 |
 Supernus Pharmaceuticals, Inc. |
Healthcare | 5.2346 | 1.99 | 3.12 | 27.96 | 11.39 | 0 |
| #7 |
 Alto Neuroscience, Inc. |
Healthcare | 5.0798 | 1.93 | 0 | -1.26 | -2.06 | 0 |
| #8 |
 AbbVie |
Healthcare | 4.6133 | 92.87 | 6.64 | 96.15 | 25.13 | 2.97 |
| #9 |
 Johnson & Johnson |
Healthcare | 4.3527 | 4.83 | 3.88 | 24.53 | 14.43 | 2.79 |
| #10 |
 NRx Pharmaceuticals, Inc. |
Healthcare | 3.5295 | -0.69 | 0 | -1.21 | -1.15 | 0 |
似ている ETF
管理会社のその他のETF
| 名前 | クラス | カテゴリ | 手数料 | 年間収益性 |
| Equity | 0.83 | 61.39 | ||
| Equity | 0.84 | -0.91 | ||
| Equity | 1.18 | 8.94 | ||
| Equity | 0.95 | -5.36 | ||
| Equity | 1.28 | 23.28 | ||
| Multi-Asset | 1.71 | 11.95 | ||
| Equity | 1.03 | 50.52 | ||
| Equity | 0.9 | 14.31 | ||
| Equity | 1.1 | 21.77 | ||
| Multi-Asset | 1.51 | 21.53 | ||
| Equity | 0.75 | 11.26 | ||
| Equity | 2.84 | -17.15 | ||
| Equity | 1 | 7.68 | ||
| Equity | 1.01 | -9.01 | ||
| Equity | 0.99 | 1.65 |
説明 AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
ソースに基づいています: porti.ru
